ATC
REGN icon

Argent Trust Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Argent Trust Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
1,922
+20
+1% +$15.3K 0.05% 287
2025
Q4 		$1.47M Sell
1,902
-284
-13% -$193K 0.05% 282
2025
Q3 		$1.23M Buy
2,186
+136
+7% +$76.9K 0.04% 305
2025
Q2 		$1.08M Sell
2,050
-96
-4% -$53.6K 0.04% 309
2025
Q1 		$1.36M Sell
2,146
-46
-2% -$31.6K 0.06% 270
2024
Q4 		$1.56M Sell
2,192
-197
-8% -$165K 0.06% 255
2024
Q3 		$2.51M Buy
2,389
+19
+0.8% +$21.1K 0.1% 183
2024
Q2 		$2.49M Buy
2,370
+31
+1% +$30.1K 0.11% 171
2024
Q1 		$2.25M Buy
2,339
+176
+8% +$167K 0.1% 190
2023
Q4 		$1.9M Buy
2,163
+96
+5% +$79.1K 0.09% 196
2023
Q3 		$1.7M Buy
2,067
+91
+5% +$71.5K 0.09% 188
2023
Q2 		$1.42M Buy
1,976
+457
+30% +$352K 0.08% 219
2023
Q1 		$1.25M Sell
1,519
-11
-0.7% -$8.3K 0.08% 210
2022
Q4 		$1.1M Sell
1,530
-39
-2% -$28.8K 0.07% 226
2022
Q3 		$1.08M Buy
1,569
+35
+2% +$22K 0.08% 217
2022
Q2 		$907K Buy
1,534
+21
+1% +$13.7K 0.06% 248
2022
Q1 		$1.06M Sell
1,513
-14
-0.9% -$8.86K 0.06% 241
2021
Q4 		$964K Buy
1,527
+1,173
+331% +$721K 0.06% 263
2021
Q3 		$214K Buy
+354
New +$220K 0.01% 502

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Argent Trust Co's REGN Position: Q1 2026 in Review

Argent Trust Co increased its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q1 2026, buying an estimated $15.3K and bringing the position to 1,922 shares worth $1.49M. The position accounts for 0.05% of the portfolio, ranked #287.

Argent Trust Co first reported a position in REGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.51M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Argent Trust Co held 1,922 shares of Regeneron Pharmaceuticals worth $1.49M as of Q1 2026.
  • Argent Trust Co bought 20 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $15.3K.
  • Regeneron Pharmaceuticals made up 0.05% of Argent Trust Co's portfolio in Q1 2026, its #287 holding.
  • Argent Trust Co first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Argent Trust Co's Regeneron Pharmaceuticals position peaked at $2.51M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.